Skip to main content

Advertisement

SpringerLink
Log in

White matter changes in breast cancer brain metastases patients who undergo radiosurgery alone compared to whole brain radiation therapy plus radiosurgery

  • Clinical Study
  • Published:
Journal of Neuro-Oncology Aims and scope Submit manuscript

Abstract

Delayed toxicity after whole brain radiation therapy (WBRT) is of increasing concern in patients who survive more than one year with brain metastases from breast cancer. Radiation-related white matter toxicity is detected by magnetic resonance imaging (MRI) and has been correlated with neurocognitive dysfunction. This study assessed the risk of developing white matter changes (WMC) in breast cancer patients who underwent either WBRT plus stereotactic radiosurgery (SRS) or SRS alone. We retrospectively compared 35 patients with breast cancer brain metastases who received WBRT and SRS to 30 patients who only received SRS. All patients had evaluable imaging at a median of one year after their initial management. The development of white matter T2 prolongation as detected by T2 or FLAIR imaging was graded: grade 1 = little or no white matter T2 hyperintensity; grade 2 = limited periventricular hyperintensity; and grade 3 = diffuse white matter hyperintensity. After WBRT plus SRS, patients demonstrated a significantly higher incidence of WMC (p < 0.0001). After one year, 71.5 % of patients whose treatment included WBRT demonstrated WMC (42.9 % grade 2; 28.6 % grade 3). Only one patient receiving only SRS developed WMC. In long-term survivors of breast cancer, the risk of WMC was significantly reduced when SRS alone was used for management. Further prospective studies are necessary to determine how these findings correlate with neurocognitive toxicity. WBRT usage as initial management of limited brain disease should be replaced by SRS alone to reduce the risk of delayed white matter toxicity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Patchell RA, Tibbs PA, Regine WF, Dempsey RJ, Mohiuddin M, Kryscio RJ, Markesbery WR, Foon KA, Young B (1998) Postoperative radiotherapy in the treatment of single metastases to the brain: a randomized trial. JAMA 280:1485–1489. doi:10.1001/jama.280.17.1485

    Article  CAS  PubMed  Google Scholar 

  2. Aoyama H, Shirato H, Tago M, Nakagawa K, Toyoda T, Hatano K, Kenjyo M, Oya N, Hirota S, Shioura H, Kunieda E, Inomata T, Hayakawa K, Katoh N, Kobashi G (2006) Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial. JAMA 295:2483–2491. doi:10.1001/jama.295.21.2483

    Article  CAS  PubMed  Google Scholar 

  3. Kocher M, Soffietti R, Abacioglu U, Villa S, Fauchon F, Baumert BG, Fariselli L, Tzuk-Shina T, Kortmann RD, Carrie C, Ben Hassel M, Kouri M, Valeinis E, van den Berge D, Collette S, Collette L, Mueller RP (2011) Adjuvant whole-brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebral metastases: results of the EORTC 22952-26001 study. J Clin Oncol 29:134–141. doi:10.1200/JCO.2010.30.1655

    Article  PubMed Central  PubMed  Google Scholar 

  4. Hall WA, Djalilian HR, Nussbaum ES, Cho KH (2000) Long-term survival with metastatic cancer to the brain. Med Oncol 17:279–286

    Article  CAS  PubMed  Google Scholar 

  5. Kondziolka D, Martin JJ, Flickinger JC, Friedland DM, Brufsky AM, Baar J, Agarwala S, Kirkwood JM, Lunsford LD (2005) Long-term survivors after gamma knife radiosurgery for brain metastases. Cancer 104:2784–2791. doi:10.1002/cncr.21545

    Article  PubMed  Google Scholar 

  6. Altundag K, Bondy ML, Mirza NQ, Kau SW, Broglio K, Hortobagyi GN, Rivera E (2007) Clinicopathologic characteristics and prognostic factors in 420 metastatic breast cancer patients with central nervous system metastasis. Cancer 110:2640–2647. doi:10.1002/cncr.23088

    Article  CAS  PubMed  Google Scholar 

  7. Burger PC, Mahley MS Jr, Dudka L, Vogel FS (1979) The morphologic effects of radiation administered therapeutically for intracranial gliomas: a postmortem study of 25 cases. Cancer 44:1256–1272

    Article  CAS  PubMed  Google Scholar 

  8. Hopewell JW (1979) Late radiation damage to the central nervous system: a radiobiological interpretation. Neuropathol Appl Neurobiol 5:329–343

    Article  CAS  PubMed  Google Scholar 

  9. Tiller-Borcich JK, Fike JR, Phillips TL, Davis RL (1987) Pathology of delayed radiation brain damage: an experimental canine model. Radiat Res 110:161–172

    Article  CAS  PubMed  Google Scholar 

  10. Panagiotakos G, Alshamy G, Chan B, Abrams R, Greenberg E, Saxena A, Bradbury M, Edgar M, Gutin P, Tabar V (2007) Long-term impact of radiation on the stem cell and oligodendrocyte precursors in the brain. PLoS One 2:e588. doi:10.1371/journal.pone.0000588

    Article  PubMed Central  PubMed  Google Scholar 

  11. Defrancesco M, Marksteiner J, Deisenhammer E, Kemmler G, Djurdjevic T, Schocke M (2013) Impact of white matter lesions and cognitive deficits on conversion from mild cognitive impairment to Alzheimer’s disease. J Alzheimers Dis 34:665–672. doi:10.3233/JAD-122095

    CAS  PubMed  Google Scholar 

  12. Pfefferbaum A, Rosenbloom M, Rohlfing T, Sullivan EV (2009) Degradation of association and projection white matter systems in alcoholism detected with quantitative fiber tracking. Biol Psychiatry 65:680–690. doi:10.1016/j.biopsych.2008.10.039

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  13. Hulst HE, Steenwijk MD, Versteeg A, Pouwels PJ, Vrenken H, Uitdehaag BM, Polman CH, Geurts JJ, Barkhof F (2013) Cognitive impairment in MS: impact of white matter integrity, gray matter volume, and lesions. Neurology 80:1025–1032. doi:10.1212/WNL.0b013e31828726cc

    Article  CAS  PubMed  Google Scholar 

  14. Fujii O, Tsujino K, Soejima T, Yoden E, Ichimiya Y, Sugimura K (2006) White matter changes on magnetic resonance imaging following whole-brain radiotherapy for brain metastases. Radiat Med 24:345–350. doi:10.1007/s11604-006-0039-9

    Article  PubMed  Google Scholar 

  15. Szerlip N, Rutter C, Ram N, Yovino S, Kwok Y, Maggio W, Regine WF (2011) Factors impacting volumetric white matter changes following whole brain radiation therapy. J Neurooncol 103:111–119. doi:10.1007/s11060-010-0358-7

    Article  PubMed  Google Scholar 

  16. Ebi J, Sato H, Nakajima M, Shishido F (2013) Incidence of leukoencephalopathy after whole-brain radiation therapy for brain metastases. Int J Radiat Oncol Biol Phys 85:1212–1217. doi:10.1016/j.ijrobp.2012.09.025

    Article  PubMed  Google Scholar 

  17. Chang EL, Wefel JS, Hess KR, Allen PK, Lang FF, Kornguth DG, Arbuckle RB, Swint JM, Shiu AS, Maor MH, Meyers CA (2009) Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial. Lancet Oncol 10:1037–1044. doi:10.1016/S1470-2045(09)70263-3

    Article  PubMed  Google Scholar 

  18. Monaco EA 3rd, Faraji AH, Berkowitz O, Parry PV, Hadelsberg U, Kano H, Niranjan A, Kondziolka D, Lunsford LD (2013) Leukoencephalopathy after whole-brain radiation therapy plus radiosurgery versus radiosurgery alone for metastatic lung cancer. Cancer 119:226–232. doi:10.1002/cncr.27504

    Article  PubMed  Google Scholar 

  19. Sperduto PW, Kased N, Roberge D, Chao ST, Shanley R, Luo X, Sneed PK, Suh J, Weil RJ, Jensen AW, Brown PD, Shih HA, Kirkpatrick J, Gaspar LE, Fiveash JB, Chiang V, Knisely JP, Sperduto CM, Lin N, Mehta M (2013) The effect of tumor subtype on the time from primary diagnosis to development of brain metastases and survival in patients with breast cancer. J Neurooncol 112:467–472. doi:10.1007/s11060-013-1083-9

    Article  PubMed  Google Scholar 

  20. Kondziolka D, Patel A, Lunsford LD, Kassam A, Flickinger JC (1999) Stereotactic radiosurgery plus whole brain radiotherapy versus radiotherapy alone for patients with multiple brain metastases. Int J Radiat Oncol Biol Phys 45:427–434

    Article  CAS  PubMed  Google Scholar 

  21. Tsuruda JS, Kortman KE, Bradley WG, Wheeler DC, Van Dalsem W, Bradley TP (1987) Radiation effects on cerebral white matter: MR evaluation. AJR Am J Roentgenol 149:165–171. doi:10.2214/ajr.149.1.165

    Article  CAS  PubMed  Google Scholar 

  22. Fazekas F, Chawluk JB, Alavi A, Hurtig HI, Zimmerman RA (1987) MR signal abnormalities at 1.5 T in Alzheimer’s dementia and normal aging. AJR Am J Roentgenol 149:351–356. doi:10.2214/ajr.149.2.351

    Article  CAS  PubMed  Google Scholar 

  23. Lagerwaard FJ, Levendag PC, Nowak PJ, Eijkenboom WM, Hanssens PE, Schmitz PI (1999) Identification of prognostic factors in patients with brain metastases: a review of 1292 patients. Int J Radiat Oncol Biol Phys 43:795–803

    Article  CAS  PubMed  Google Scholar 

  24. Nieder C, Nestle U, Motaref B, Walter K, Niewald M, Schnabel K (2000) Prognostic factors in brain metastases: should patients be selected for aggressive treatment according to recursive partitioning analysis (RPA) classes? Int J Radiat Oncol Biol Phys 46:297–302

    Article  CAS  PubMed  Google Scholar 

  25. Borgelt B, Gelber R, Kramer S, Brady LW, Chang CH, Davis LW, Perez CA, Hendrickson FR (1980) The palliation of brain metastases: final results of the first two studies by the radiation therapy oncology group. Int J Radiat Oncol Biol Phys 6:1–9

    Article  CAS  PubMed  Google Scholar 

  26. Borgelt B, Gelber R, Larson M, Hendrickson F, Griffin T, Roth R (1981) Ultra-rapid high dose irradiation schedules for the palliation of brain metastases: final results of the first two studies by the radiation therapy oncology group. Int J Radiat Oncol Biol Phys 7:1633–1638

    Article  CAS  PubMed  Google Scholar 

  27. Komarnicky LT, Phillips TL, Martz K, Asbell S, Isaacson S, Urtasun R (1991) A randomized phase III protocol for the evaluation of misonidazole combined with radiation in the treatment of patients with brain metastases (RTOG-7916). Int J Radiat Oncol Biol Phys 20:53–58

    Article  CAS  PubMed  Google Scholar 

  28. Phillips TL, Scott CB, Leibel SA, Rotman M, Weigensberg IJ (1995) Results of a randomized comparison of radiotherapy and bromodeoxyuridine with radiotherapy alone for brain metastases: report of RTOG trial 89-05. Int J Radiat Oncol Biol Phys 33:339–348. doi:10.1016/0360-3016(95)00168-X

    Article  CAS  PubMed  Google Scholar 

  29. Brown PD, Pugh S, Laack NN, Wefel JS, Khuntia D, Meyers C, Choucair A, Fox S, Suh JH, Roberge D, Kavadi V, Bentzen SM, Mehta MP, Watkins-Bruner D, Radiation Therapy Oncology G (2013) Memantine for the prevention of cognitive dysfunction in patients receiving whole-brain radiotherapy: a randomized, double-blind, placebo-controlled trial. Neuro Oncol 15:1429–1437. doi:10.1093/neuonc/not114

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  30. Nieder C, Spanne O, Mehta MP, Grosu AL, Geinitz H (2011) Presentation, patterns of care, and survival in patients with brain metastases: what has changed in the last 20 years? Cancer 117:2505–2512. doi:10.1002/cncr.25707

    Article  PubMed  Google Scholar 

  31. Rades D, Schild SE (2012) Do patients with a limited number of brain metastases need whole-brain radiotherapy in addition to radiosurgery? Strahlenther Onkol 188:702–706. doi:10.1007/s00066-012-0093-4

    Article  CAS  PubMed  Google Scholar 

  32. Soffietti R, Kocher M, Abacioglu UM, Villa S, Fauchon F, Baumert BG, Fariselli L, Tzuk-Shina T, Kortmann RD, Carrie C, Ben Hassel M, Kouri M, Valeinis E, van den Berge D, Mueller RP, Tridello G, Collette L, Bottomley A (2013) A European organisation for research and treatment of cancer phase III trial of adjuvant whole-brain radiotherapy versus observation in patients with one to three brain metastases from solid tumors after surgical resection or radiosurgery: quality-of-life results. J Clin Oncol 31:65–72. doi:10.1200/JCO.2011.41.0639

    Article  PubMed  Google Scholar 

  33. Conill C, Berenguer J, Vargas M, Lopez-Soriano A, Valduvieco I, Marruecos J, Vilella R (2007) Incidence of radiation-induced leukoencephalopathy after whole brain radiotherapy in patients with brain metastases. Clin Transl Oncol 9:590–595

    Article  CAS  PubMed  Google Scholar 

  34. Chawla S, Wang S, Kim S, Sheriff S, Lee P, Rengan R, Lin A, Melhem E, Maudsley A, Poptani H (2013) Radiation injury to the normal brain measured by 3D-echo-planar spectroscopic imaging and diffusion tensor imaging: initial experience. J Neuroimaging. doi:10.1111/jon.12070

    PubMed  Google Scholar 

  35. Lao CD, Friedman J, Tsien CI, Normolle DP, Chapman C, Cao Y, Lee O, Schipper M, Van Poznak C, Hamstra D, Lawrence T, Hayman J, Redman BG (2013) Concurrent whole brain radiotherapy and bortezomib for brain metastasis. Radiat Oncol 8:204. doi:10.1186/1748-717X-8-204

    Article  PubMed Central  PubMed  Google Scholar 

  36. Sheehan JP, Sun MH, Kondziolka D, Flickinger J, Lunsford LD (2002) Radiosurgery for non-small cell lung carcinoma metastatic to the brain: long-term outcomes and prognostic factors influencing patient survival time and local tumor control. J Neurosurg 97:1276–1281. doi:10.3171/jns.2002.97.6.1276

    Article  PubMed  Google Scholar 

  37. Monaco E 3rd, Kondziolka D, Mongia S, Niranjan A, Flickinger JC, Lunsford LD (2008) Management of brain metastases from ovarian and endometrial carcinoma with stereotactic radiosurgery. Cancer 113:2610–2614. doi:10.1002/cncr.23868

    Article  PubMed  Google Scholar 

  38. Kano H, Iyer A, Kondziolka D, Niranjan A, Flickinger JC, Lunsford LD (2011) Outcome predictors of gamma knife radiosurgery for renal cell carcinoma metastases. Neurosurgery 69:1232–1239. doi:10.1227/NEU.0b013e31822b2fdc

    Article  PubMed  Google Scholar 

  39. Kondziolka D, Kano H, Harrison GL, Yang HC, Liew DN, Niranjan A, Brufsky AM, Flickinger JC, Lunsford LD (2011) Stereotactic radiosurgery as primary and salvage treatment for brain metastases from breast cancer. Clinical article. J Neurosurg 114:792–800. doi:10.3171/2010.8.JNS10461

    Article  Google Scholar 

  40. Liew DN, Kano H, Kondziolka D, Mathieu D, Niranjan A, Flickinger JC, Kirkwood JM, Tarhini A, Moschos S, Lunsford LD (2011) Outcome predictors of Gamma Knife surgery for melanoma brain metastases: clinical article. J Neurosurg 114:769–779. doi:10.3171/2010.5.JNS1014

    Article  PubMed  Google Scholar 

  41. Tooze A, Hiles CL, Sheehan JP (2012) Neurocognitive changes in pituitary adenoma patients after gamma knife radiosurgery: a preliminary study. World Neurosurg 78:122–128. doi:10.1016/j.wneu.2011.09.010S1878-8750(11)01089-8

    Article  PubMed  Google Scholar 

  42. Zimm S, Wampler GL, Stablein D, Hazra T, Young HF (1981) Intracerebral metastases in solid-tumor patients: natural history and results of treatment. Cancer 48:384–394

    Article  CAS  PubMed  Google Scholar 

  43. Pegram M, Liao J (2012) Trastuzumab treatment in multiple lines: current data and future directions. Clin Breast Cancer 12:10–18. doi:10.1016/j.clbc.2011.07.003S1526-8209(11)00155-8

    Article  CAS  PubMed  Google Scholar 

  44. Kondziolka D, Niranjan A, Flickinger JC, Lunsford LD (2005) Radiosurgery with or without whole-brain radiotherapy for brain metastases: the patients’ perspective regarding complications. Am J Clin Oncol 28:173–179 00000421-200504000-00014

    Article  PubMed  Google Scholar 

  45. Ahles TA, Saykin AJ (2007) Candidate mechanisms for chemotherapy-induced cognitive changes. Nat Rev Cancer 7:192–201. doi:10.1038/nrc2073

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  46. Meyers CA, Smith JA, Bezjak A, Mehta MP, Liebmann J, Illidge T, Kunkler I, Caudrelier JM, Eisenberg PD, Meerwaldt J, Siemers R, Carrie C, Gaspar LE, Curran W, Phan SC, Miller RA, Renschler MF (2004) Neurocognitive function and progression in patients with brain metastases treated with whole-brain radiation and motexafin gadolinium: results of a randomized phase III trial. J Clin Oncol 22:157–165. doi:10.1200/JCO.2004.05.128

    Article  CAS  PubMed  Google Scholar 

  47. Aoyama H, Tago M, Kato N, Toyoda T, Kenjyo M, Hirota S, Shioura H, Inomata T, Kunieda E, Hayakawa K, Nakagawa K, Kobashi G, Shirato H (2007) Neurocognitive function of patients with brain metastasis who received either whole brain radiotherapy plus stereotactic radiosurgery or radiosurgery alone. Int J Radiat Oncol Biol Phys 68:1388–1395. doi:10.1016/j.ijrobp.2007.03.048

    Article  PubMed  Google Scholar 

  48. Lyu J, Lee SH (2012) Gender differences in the link between excessive drinking and domain-specific cognitive functioning among older adults. J Aging Health 24:1380–1398. doi:10.1177/0898264312459346

    Article  PubMed  Google Scholar 

  49. Alfonso-Loeches S, Pascual M, Guerri C (2013) Gender differences in alcohol-induced neurotoxicity and brain damage. Toxicology 311:27–34. doi:10.1016/j.tox.2013.03.001S0300-483X(13)00063-2

    Article  CAS  PubMed  Google Scholar 

  50. Baschnagel AM, Meyer KD, Chen PY, Krauss DJ, Olson RE, Pieper DR, Maitz AH, Ye H, Grills IS (2013) Tumor volume as a predictor of survival and local control in patients with brain metastases treated with gamma knife surgery. J Neurosurg 119:1139–1144. doi:10.3171/2013.7.JNS13431

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

There was no funding source for the research described in this manuscript.

Author information

Authors and Affiliations

  1. Department of Neurological Surgery, University of Pittsburgh Medical Center, Pittsburgh, PA, 15213, USA

    Timothy B. Stokes, Ajay Niranjan, Hideyuki Kano, Phillip A. Choi, L. Dade Lunsford & Edward A. Monaco III

  2. Department of Neurosurgery, New York University Langone Medical Center, New York, NY, 10016, USA

    Douglas Kondziolka

Authors
  1. Timothy B. Stokes
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ajay Niranjan
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Hideyuki Kano
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Phillip A. Choi
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Douglas Kondziolka
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. L. Dade Lunsford
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Edward A. Monaco III
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Edward A. Monaco III.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Stokes, T.B., Niranjan, A., Kano, H. et al. White matter changes in breast cancer brain metastases patients who undergo radiosurgery alone compared to whole brain radiation therapy plus radiosurgery. J Neurooncol 121, 583–590 (2015). https://doi.org/10.1007/s11060-014-1670-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11060-014-1670-4

Keywords

Search

Navigation